INS and hyperlipidemia: This study, in addition to previous evidence of butyrate effect in increasing fatty acid oxidation in the liver, muscle and brown adipose tissue, suggests that butyrate may also target white adipocytes to combat hyperlipidemia and enhance insulin sensitivity.